All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Idera Pharmaceuticals Inc., of Cambridge, Mass., reported publication of a study supporting the potential role of the suppression of Toll-like receptors (TLRs) 7, 8 and 9 to treat psoriasis in PLOS One.